Efficacy and safety of neoadjuvant chemotherapy with concurrent liposomal-encapsulated doxorubicin, paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive breast cancer in clinical practice
Titel:
Efficacy and safety of neoadjuvant chemotherapy with concurrent liposomal-encapsulated doxorubicin, paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive breast cancer in clinical practice
Auteur:
Gavilá, Joaquín Guerrero, Ángel Climent, Miguel Ángel Fernández, Aranzazu Gozalbo, Francisco Carrascosa, María Camps, Josefina Guillem, Vicente Ruiz, Amparo